SlideShare una empresa de Scribd logo
1 de 37
Validity Of A Screening Test
Dr. Kulrajat Bhasin
1
• Definitions
• Objective
• Sensitivity & Specificity
• Concept of false positives and false negatives
• Tests for continuous variables
• Combination of tests and effects
• Predictive value of a test
• Determining cut-off point
• ROC curve 2
Plan Of Presentation
Definition
• The process by which unrecognized disease or defects are
identified by means of rapidly applied tests, examination or
other procedures in apparently healthy individuals on a
large scale.
• Differs from periodic health exam as:
i. Capable of wide application
ii. Relatively inexpensive
iii.Physician has to only interpret it and hence saves time.
3
Aims And Objectives
• To sort out from a large group of apparently
healthy people, those likely to have disease or
are at an increased risk.
• To bring those who are apparently abnormal
under supervision, confirmation and treatment if
required.
4
Three Key Measures Of Validity
1. SENSITIVITY
2. SPECIFICITY
3. PREDICTIVE VALUE
5
• The above figure is a bimodal distribution of a
variable in the normal and diseased populations.
• Below is a fig representing unimodal distribution.
6
7
Validity Of Screening Tests
• The validity of a screening test is defined as its ability to
distinguish between who has a disease and who does not and
has 2 components:
 Sensitivity : defined as ability of a test to identify correctly
those who have the disease or true positives.
 Specificity : defined as the ability of a test to identify correctly
those who do not have a disease or true negatives.
8
9
Screening
test results
Diagnosis
Total
Present Absent
Positive a (True positive) b (False positive) a + b
Negative c (False negative) d (True negative) c + d
Total a + c b + d a+b+c+d
Sensitivity
It is defined as the ability of a test to identify correctly
all those who have the disease, that is "true positive".
x 100 x100
• A test has 90% sensitivity means: 90 per cent of the
diseased people screened by the test will give a "true
positive" result and the remaining 10 per cent a "false
negative" result.
(TP)
(TP+FN)
(a)
(a + c)
OR
10
Specificity
It is defined as the ability of a test to identify correctly those who do not
have the disease, that is, "true negatives".
x 100 x 100
• 90 per cent specificity means: 90 per cent of the non diseased
persons will give "true negative" result and 10 per cent of non-
diseased people screened by the test will be wrongly classified as
"diseased" when they are not (False positives).
(TN)
(FP+TN)
OR
(d)
(b + d)
11
12
Percentage Of False Positives:
x
• Means that patients who do not have the disease
are told that they have the disease.
• Further diagnostic test.
• Inconvenience, discomfort, anxiety & unnecessary
expense.
(b)
(b + d)
100
13
Percentage Of False Negatives:
x
• Means that patients who actually have the disease are
told that they do not have the disease.
• False Re-assurance.
• Might ignore the development of signs & symptoms.
• Postpone treatment.
• IMPORTANT IN SERIOUS DISEASE.
(c)
(a + c)
100
14
• At times we need to test for a continuous variable,
e.g. BP or blood sugar level for which there is no
“positive” or “negative result”.
• A decision must therefore be made in establishing a
cut-off level above which a test result is considered
positive and below which a result is considered
negative.
15
Tests For Continuous Variables
16
3 2
7 8
7 5
3 5
DIABETIC
DIABETIC DIABETICNON-DIABETIC
NON-DIABETIC
NON-DIABETIC
HIGH
HIGH
HIGH
DIABETIC
DIABETIC NON-DIABETIC
NON-DIABETIC
BLOOD
SUGAR BLOOD
SUGAR
BLOOD
SUGAR
LOW
LOW
LOW
10 10
10 10
+
+
-
-
Screening For Diabetes In Hypothetical Population With A Prevalence Of 50 %.
Effects Of Choosing Different Cutoff Levels For A Positive Test:
A B
C
17
HIGH
HIGH
HIGH
BLOOD
SUGAR
BLOOD
SUGAR
BLOOD
SUGAR
LOW LOW
LOW
HIGH
BLOOD
SUGAR
LOW
D E
F G
18
19
Combination Of Tests
• Two or more tests can be used in combination to
enhance the sensitivity or specificity of screening.
E.g. for syphilis, pts. first evaluated by RPR test,
whose sensitivity is high but still gives false
positives, hence the second test is applied, e.g.
FTA – ABS which is a more specific test and the
resultant positives are true positives.
• Sequential (two stage) and simultaneous testing.
20
• We can calculate the net sensitivity and specificity by using both tests in sequence.
• After finishing both tests 315 people of 500 actual diabetics in the 10,000 population
have been correctly called positive, hence 63 % net sensitivity (loss).
• 7600 of 9500 in this population who never had DM were correctly called negative by
the first test and were not tested further, while an addl 1710 of those 9500 were
correctly called negative by 2nd
test hence 7600 + 1710/9500 x 100, i.e. 98 % net
specificity (gain).
21
Sequential (Two Stage) Testing
22
Simultaneous Testing
Total population: 1000 ; prevalence: 20%
…In Summary
23
• In sequential testing, there is a net loss in sensitivity but a
net gain in specificity compared with results by either test
alone.
• In simultaneous testing, there is a net gain in sensitivity but
a net loss in specificity compared with either tests done
alone.
• Hence the decision to use either of the above methods
depends upon whether they’re being done for screening or
diagnosis as well as on considerations of practicality, i.e.
setting in which testing is being done, costs, length of
hospital stay, degree of invasiveness, as well as third party
insurance coverage.
Predictive Values Of A Test :
• Useful to know what proportion of patients with abnormal test
results are truly abnormal.
• They reflect the diagnostic power of a test.
Positive Predictive Value:
The "predictive value of a positive test" indicates the probability that
a patient with a positive test result has, in fact, the disease in
question.
• Proportion of patients with positive test results who are correctly
diagnosed.
• PPV of 90% means that 90% of the patients who are diagnosed to be
positive by the test in fact have the disease in question.
x
(a)
(a + b)
100
24
Negative Predictive Value:
The "predictive value of a negative test" indicates the probability that a
patient with a negative test result doesn't have disease in question.
• NPV of 90% means that 90% of the patients who are diagnosed to be
negative by the test do not have the disease in question.
x
(d)
(c + d)
100
25
Calculating The Rates
A test is used in 50 people with disease and 50 people
without. These are the results:
Disease
+ -
Test
+ 48 3 51
- 2 47 49
50 50 100
26
Sensitivity = 48/50 = 96%
Specificity = 47/50 = 94%
Positive predictive value = 48/51 = 94%
Negative predictive value = 47/49 = 96%
Disease
+ -
Test
+ 48 3 51
- 2 47 49
50 50 100
27
Effect of Prevalence :
• Predictive values depend strongly on prevalence of the
condition.
• As the prevalence of the condition increases positive
predictive value increases and thus more chances of getting
true positive results.
• If the condition is uncommon it is more sure that the
negative test indicates no abnormality.
28
• Higher the prevalence, higher is the predictive value.
• Hence a screening program is most productive and
efficient when it is directed to high risk target
population. 29
Relationship B/W Predictive Value And Disease
Prevalence
Amount of previous unrecognized disease diagnosed as a
result of screening effort.
•Depends on
Sensitivity, specificity.
Prevalence of disease.
Participation of individuals.
• High risk populations selected for screening – 40 yrs.
above adults for diabetes.
30
Yield
Determining The Cutoff Point
The factors to be considered are :
• Disease prevalence : when prevalence of the disease is
high in the community the cut-off point is set at low
level.
This will increase the sensitivity.
• The disease : if the disease is very lethal and early
intervention markedly increases the prognosis, cut off
point is set at lower level.
31
Receiver Operating Characteristic (ROC) Curve
• The cutoff point for a disease is best determined using ROC curve.
• As no single value cutoff point of an individual test can be expected to have
both perfect sensitivity and specificity, it is often necessary to determine
which value or cut off point is most appropriate for a given purpose.
• Receiver Operating Characteristic (ROC) Curve is a graph displaying the
relationship between true positive rate (on vertical axis) and false positive
rate (on horizontal axis).
• The ROC curve was first used during world war 2 for the analysis of RADAR
signals for the detection of enemy objects entering the battle field.
32
• A perfect test can be represented by drawing a line along the Y-axis
and horizontal line on the top.
• ROC curve of most of the tests appear as a curved line. Better the test,
closer the curve approaches depiction of perfect test.
33
34
Uses Of ROC Curve:
1. ROC curve helps to choose the critical cut-off value which best discriminates
the presence or absence of a disease.
- At which the curve’s deviation is maximum.
-Where the perpendicular distance from the line equality is maximum.
35
Test A Test B
Uses Of ROC Curve:
2. Another use of ROC curve is to compare two indicators.
The curve that contains a large area below it is a better predictor than
one below with a smaller area.
References
• Park K. Park’s textbook of preventive and social medicine.
22nd
ed. Jabalpur(India): Banarsidas Bhanot; 2012. p127-134.
• Leon Gordis, Text book of epidemiology.4th
ed.Saunders:
Elsevier Inc.; 2009.p.85-108
• Sukon Kanchanaraksa.Evaluation of diagnostic and screening
tests: validity and reliability, 1st
edition. John hopkins
bloomberg school of public health. 2011. p 1 – 124.
36
37

Más contenido relacionado

La actualidad más candente

Validity and Reliability
Validity and Reliability Validity and Reliability
Validity and Reliability
Tauseef Jawaid
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
Bhumika Bhatt
 
Association and causation
Association and causationAssociation and causation
Association and causation
drravimr
 

La actualidad más candente (20)

CASE CONTROL STUDY
CASE CONTROL STUDYCASE CONTROL STUDY
CASE CONTROL STUDY
 
Advance concepts in screening
Advance concepts in screeningAdvance concepts in screening
Advance concepts in screening
 
Disease screening
Disease screeningDisease screening
Disease screening
 
Secondary attack rates
Secondary attack ratesSecondary attack rates
Secondary attack rates
 
Criteria for screening
Criteria for screeningCriteria for screening
Criteria for screening
 
Measuring Disease Frequency
Measuring Disease FrequencyMeasuring Disease Frequency
Measuring Disease Frequency
 
Epidemic Curve
Epidemic CurveEpidemic Curve
Epidemic Curve
 
Attributable risk and population attributable risk
Attributable risk and population attributable riskAttributable risk and population attributable risk
Attributable risk and population attributable risk
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
Validity and Reliability
Validity and Reliability Validity and Reliability
Validity and Reliability
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studies
 
Association causation
Association causationAssociation causation
Association causation
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
 
Confounder and effect modification
Confounder and effect modificationConfounder and effect modification
Confounder and effect modification
 
Association and causation
Association and causationAssociation and causation
Association and causation
 
Sample size calculations
Sample size calculationsSample size calculations
Sample size calculations
 
Sampling and sampling technique
Sampling and sampling techniqueSampling and sampling technique
Sampling and sampling technique
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
 
Epidemiological Exercises on case control studies
Epidemiological Exercises on case control studiesEpidemiological Exercises on case control studies
Epidemiological Exercises on case control studies
 

Destacado (7)

Diagnosis, sensitivity and specificity
Diagnosis, sensitivity and specificityDiagnosis, sensitivity and specificity
Diagnosis, sensitivity and specificity
 
How to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curveHow to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curve
 
Roc
RocRoc
Roc
 
The clinical laboratory
The clinical laboratoryThe clinical laboratory
The clinical laboratory
 
Sensitivity Analysis
Sensitivity AnalysisSensitivity Analysis
Sensitivity Analysis
 
Sensitivity, specificity and likelihood ratios
Sensitivity, specificity and likelihood ratiosSensitivity, specificity and likelihood ratios
Sensitivity, specificity and likelihood ratios
 
An Introduction to Supervised Machine Learning and Pattern Classification: Th...
An Introduction to Supervised Machine Learning and Pattern Classification: Th...An Introduction to Supervised Machine Learning and Pattern Classification: Th...
An Introduction to Supervised Machine Learning and Pattern Classification: Th...
 

Similar a Validity of a screening test

Lecture 3 -Screening tests.ppt presentation
Lecture 3 -Screening tests.ppt presentationLecture 3 -Screening tests.ppt presentation
Lecture 3 -Screening tests.ppt presentation
NellyPhiri5
 
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptxEpidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
Bhoj Raj Singh
 
SCREENING.pptx
SCREENING.pptxSCREENING.pptx
SCREENING.pptx
KUYA KABALO
 
Evidence-based diagnosis
Evidence-based diagnosisEvidence-based diagnosis
Evidence-based diagnosis
Hesham Gaber
 

Similar a Validity of a screening test (20)

VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptxVALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
 
Diagnostic test and agreement.pptx
Diagnostic test and agreement.pptxDiagnostic test and agreement.pptx
Diagnostic test and agreement.pptx
 
CAT 1 -MPH 5101 - FOUNDATIONS OF EPIDEMIOLOGY (1).pptx
CAT 1 -MPH 5101 -  FOUNDATIONS OF EPIDEMIOLOGY  (1).pptxCAT 1 -MPH 5101 -  FOUNDATIONS OF EPIDEMIOLOGY  (1).pptx
CAT 1 -MPH 5101 - FOUNDATIONS OF EPIDEMIOLOGY (1).pptx
 
Lecture 3 -Screening tests.ppt presentation
Lecture 3 -Screening tests.ppt presentationLecture 3 -Screening tests.ppt presentation
Lecture 3 -Screening tests.ppt presentation
 
Advance concept of screening_Nabaraj Paudel
Advance concept of screening_Nabaraj PaudelAdvance concept of screening_Nabaraj Paudel
Advance concept of screening_Nabaraj Paudel
 
Diagnostic test
Diagnostic test Diagnostic test
Diagnostic test
 
screening for diseases.pptx . ...
screening for diseases.pptx .             ...screening for diseases.pptx .             ...
screening for diseases.pptx . ...
 
.Screening tests
.Screening tests.Screening tests
.Screening tests
 
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptxEpidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
 
SCREENING.pptx
SCREENING.pptxSCREENING.pptx
SCREENING.pptx
 
Evidence-based diagnosis
Evidence-based diagnosisEvidence-based diagnosis
Evidence-based diagnosis
 
Evidence based diagnosis
Evidence based diagnosisEvidence based diagnosis
Evidence based diagnosis
 
Screening
ScreeningScreening
Screening
 
clinical evaluation of diagnostic methods.pptx
clinical evaluation of diagnostic methods.pptxclinical evaluation of diagnostic methods.pptx
clinical evaluation of diagnostic methods.pptx
 
Dr Amit Diagnostic Tests.pptx
Dr Amit Diagnostic Tests.pptxDr Amit Diagnostic Tests.pptx
Dr Amit Diagnostic Tests.pptx
 
screening.pptx
screening.pptxscreening.pptx
screening.pptx
 
screening-140217071714-phpapp02.pdf
screening-140217071714-phpapp02.pdfscreening-140217071714-phpapp02.pdf
screening-140217071714-phpapp02.pdf
 
Probability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for RProbability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for R
 
1 - Diagnostic methods.pdf
1 - Diagnostic methods.pdf1 - Diagnostic methods.pdf
1 - Diagnostic methods.pdf
 
Screening and diagnostic testing
Screening and diagnostic  testingScreening and diagnostic  testing
Screening and diagnostic testing
 

Último

Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...
Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...
Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...
gajnagarg
 
Lecture_2_Deep_Learning_Overview-newone1
Lecture_2_Deep_Learning_Overview-newone1Lecture_2_Deep_Learning_Overview-newone1
Lecture_2_Deep_Learning_Overview-newone1
ranjankumarbehera14
 
Jual Cytotec Asli Obat Aborsi No. 1 Paling Manjur
Jual Cytotec Asli Obat Aborsi No. 1 Paling ManjurJual Cytotec Asli Obat Aborsi No. 1 Paling Manjur
Jual Cytotec Asli Obat Aborsi No. 1 Paling Manjur
ptikerjasaptiker
 
怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制
怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制
怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制
vexqp
 
一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格
一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格
一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格
q6pzkpark
 
Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...
nirzagarg
 
怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制
怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制
怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制
vexqp
 
PLE-statistics document for primary schs
PLE-statistics document for primary schsPLE-statistics document for primary schs
PLE-statistics document for primary schs
cnajjemba
 
Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...
Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...
Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...
gajnagarg
 
Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...
Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...
Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...
Klinik kandungan
 
怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制
怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制
怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制
vexqp
 
Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...
nirzagarg
 

Último (20)

Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...
Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...
Top profile Call Girls In Chandrapur [ 7014168258 ] Call Me For Genuine Model...
 
Lecture_2_Deep_Learning_Overview-newone1
Lecture_2_Deep_Learning_Overview-newone1Lecture_2_Deep_Learning_Overview-newone1
Lecture_2_Deep_Learning_Overview-newone1
 
SR-101-01012024-EN.docx Federal Constitution of the Swiss Confederation
SR-101-01012024-EN.docx  Federal Constitution  of the Swiss ConfederationSR-101-01012024-EN.docx  Federal Constitution  of the Swiss Confederation
SR-101-01012024-EN.docx Federal Constitution of the Swiss Confederation
 
Jual Cytotec Asli Obat Aborsi No. 1 Paling Manjur
Jual Cytotec Asli Obat Aborsi No. 1 Paling ManjurJual Cytotec Asli Obat Aborsi No. 1 Paling Manjur
Jual Cytotec Asli Obat Aborsi No. 1 Paling Manjur
 
5CL-ADBA,5cladba, Chinese supplier, safety is guaranteed
5CL-ADBA,5cladba, Chinese supplier, safety is guaranteed5CL-ADBA,5cladba, Chinese supplier, safety is guaranteed
5CL-ADBA,5cladba, Chinese supplier, safety is guaranteed
 
怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制
怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制
怎样办理伦敦大学城市学院毕业证(CITY毕业证书)成绩单学校原版复制
 
一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格
一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格
一比一原版(曼大毕业证书)曼尼托巴大学毕业证成绩单留信学历认证一手价格
 
Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Satna [ 7014168258 ] Call Me For Genuine Models We ...
 
Discover Why Less is More in B2B Research
Discover Why Less is More in B2B ResearchDiscover Why Less is More in B2B Research
Discover Why Less is More in B2B Research
 
怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制
怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制
怎样办理圣地亚哥州立大学毕业证(SDSU毕业证书)成绩单学校原版复制
 
PLE-statistics document for primary schs
PLE-statistics document for primary schsPLE-statistics document for primary schs
PLE-statistics document for primary schs
 
Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...
Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...
Top profile Call Girls In bhavnagar [ 7014168258 ] Call Me For Genuine Models...
 
SAC 25 Final National, Regional & Local Angel Group Investing Insights 2024 0...
SAC 25 Final National, Regional & Local Angel Group Investing Insights 2024 0...SAC 25 Final National, Regional & Local Angel Group Investing Insights 2024 0...
SAC 25 Final National, Regional & Local Angel Group Investing Insights 2024 0...
 
Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...
Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...
Jual obat aborsi Bandung ( 085657271886 ) Cytote pil telat bulan penggugur ka...
 
怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制
怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制
怎样办理伦敦大学毕业证(UoL毕业证书)成绩单学校原版复制
 
Digital Transformation Playbook by Graham Ware
Digital Transformation Playbook by Graham WareDigital Transformation Playbook by Graham Ware
Digital Transformation Playbook by Graham Ware
 
DATA SUMMIT 24 Building Real-Time Pipelines With FLaNK
DATA SUMMIT 24  Building Real-Time Pipelines With FLaNKDATA SUMMIT 24  Building Real-Time Pipelines With FLaNK
DATA SUMMIT 24 Building Real-Time Pipelines With FLaNK
 
Capstone in Interprofessional Informatic // IMPACT OF COVID 19 ON EDUCATION
Capstone in Interprofessional Informatic  // IMPACT OF COVID 19 ON EDUCATIONCapstone in Interprofessional Informatic  // IMPACT OF COVID 19 ON EDUCATION
Capstone in Interprofessional Informatic // IMPACT OF COVID 19 ON EDUCATION
 
Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...
Top profile Call Girls In Hapur [ 7014168258 ] Call Me For Genuine Models We ...
 
Harnessing the Power of GenAI for BI and Reporting.pptx
Harnessing the Power of GenAI for BI and Reporting.pptxHarnessing the Power of GenAI for BI and Reporting.pptx
Harnessing the Power of GenAI for BI and Reporting.pptx
 

Validity of a screening test

  • 1. Validity Of A Screening Test Dr. Kulrajat Bhasin 1
  • 2. • Definitions • Objective • Sensitivity & Specificity • Concept of false positives and false negatives • Tests for continuous variables • Combination of tests and effects • Predictive value of a test • Determining cut-off point • ROC curve 2 Plan Of Presentation
  • 3. Definition • The process by which unrecognized disease or defects are identified by means of rapidly applied tests, examination or other procedures in apparently healthy individuals on a large scale. • Differs from periodic health exam as: i. Capable of wide application ii. Relatively inexpensive iii.Physician has to only interpret it and hence saves time. 3
  • 4. Aims And Objectives • To sort out from a large group of apparently healthy people, those likely to have disease or are at an increased risk. • To bring those who are apparently abnormal under supervision, confirmation and treatment if required. 4
  • 5. Three Key Measures Of Validity 1. SENSITIVITY 2. SPECIFICITY 3. PREDICTIVE VALUE 5
  • 6. • The above figure is a bimodal distribution of a variable in the normal and diseased populations. • Below is a fig representing unimodal distribution. 6
  • 7. 7
  • 8. Validity Of Screening Tests • The validity of a screening test is defined as its ability to distinguish between who has a disease and who does not and has 2 components:  Sensitivity : defined as ability of a test to identify correctly those who have the disease or true positives.  Specificity : defined as the ability of a test to identify correctly those who do not have a disease or true negatives. 8
  • 9. 9 Screening test results Diagnosis Total Present Absent Positive a (True positive) b (False positive) a + b Negative c (False negative) d (True negative) c + d Total a + c b + d a+b+c+d
  • 10. Sensitivity It is defined as the ability of a test to identify correctly all those who have the disease, that is "true positive". x 100 x100 • A test has 90% sensitivity means: 90 per cent of the diseased people screened by the test will give a "true positive" result and the remaining 10 per cent a "false negative" result. (TP) (TP+FN) (a) (a + c) OR 10
  • 11. Specificity It is defined as the ability of a test to identify correctly those who do not have the disease, that is, "true negatives". x 100 x 100 • 90 per cent specificity means: 90 per cent of the non diseased persons will give "true negative" result and 10 per cent of non- diseased people screened by the test will be wrongly classified as "diseased" when they are not (False positives). (TN) (FP+TN) OR (d) (b + d) 11
  • 12. 12
  • 13. Percentage Of False Positives: x • Means that patients who do not have the disease are told that they have the disease. • Further diagnostic test. • Inconvenience, discomfort, anxiety & unnecessary expense. (b) (b + d) 100 13
  • 14. Percentage Of False Negatives: x • Means that patients who actually have the disease are told that they do not have the disease. • False Re-assurance. • Might ignore the development of signs & symptoms. • Postpone treatment. • IMPORTANT IN SERIOUS DISEASE. (c) (a + c) 100 14
  • 15. • At times we need to test for a continuous variable, e.g. BP or blood sugar level for which there is no “positive” or “negative result”. • A decision must therefore be made in establishing a cut-off level above which a test result is considered positive and below which a result is considered negative. 15 Tests For Continuous Variables
  • 16. 16 3 2 7 8 7 5 3 5 DIABETIC DIABETIC DIABETICNON-DIABETIC NON-DIABETIC NON-DIABETIC HIGH HIGH HIGH DIABETIC DIABETIC NON-DIABETIC NON-DIABETIC BLOOD SUGAR BLOOD SUGAR BLOOD SUGAR LOW LOW LOW 10 10 10 10 + + - - Screening For Diabetes In Hypothetical Population With A Prevalence Of 50 %. Effects Of Choosing Different Cutoff Levels For A Positive Test: A B C
  • 18. 18
  • 19. 19
  • 20. Combination Of Tests • Two or more tests can be used in combination to enhance the sensitivity or specificity of screening. E.g. for syphilis, pts. first evaluated by RPR test, whose sensitivity is high but still gives false positives, hence the second test is applied, e.g. FTA – ABS which is a more specific test and the resultant positives are true positives. • Sequential (two stage) and simultaneous testing. 20
  • 21. • We can calculate the net sensitivity and specificity by using both tests in sequence. • After finishing both tests 315 people of 500 actual diabetics in the 10,000 population have been correctly called positive, hence 63 % net sensitivity (loss). • 7600 of 9500 in this population who never had DM were correctly called negative by the first test and were not tested further, while an addl 1710 of those 9500 were correctly called negative by 2nd test hence 7600 + 1710/9500 x 100, i.e. 98 % net specificity (gain). 21 Sequential (Two Stage) Testing
  • 23. …In Summary 23 • In sequential testing, there is a net loss in sensitivity but a net gain in specificity compared with results by either test alone. • In simultaneous testing, there is a net gain in sensitivity but a net loss in specificity compared with either tests done alone. • Hence the decision to use either of the above methods depends upon whether they’re being done for screening or diagnosis as well as on considerations of practicality, i.e. setting in which testing is being done, costs, length of hospital stay, degree of invasiveness, as well as third party insurance coverage.
  • 24. Predictive Values Of A Test : • Useful to know what proportion of patients with abnormal test results are truly abnormal. • They reflect the diagnostic power of a test. Positive Predictive Value: The "predictive value of a positive test" indicates the probability that a patient with a positive test result has, in fact, the disease in question. • Proportion of patients with positive test results who are correctly diagnosed. • PPV of 90% means that 90% of the patients who are diagnosed to be positive by the test in fact have the disease in question. x (a) (a + b) 100 24
  • 25. Negative Predictive Value: The "predictive value of a negative test" indicates the probability that a patient with a negative test result doesn't have disease in question. • NPV of 90% means that 90% of the patients who are diagnosed to be negative by the test do not have the disease in question. x (d) (c + d) 100 25
  • 26. Calculating The Rates A test is used in 50 people with disease and 50 people without. These are the results: Disease + - Test + 48 3 51 - 2 47 49 50 50 100 26
  • 27. Sensitivity = 48/50 = 96% Specificity = 47/50 = 94% Positive predictive value = 48/51 = 94% Negative predictive value = 47/49 = 96% Disease + - Test + 48 3 51 - 2 47 49 50 50 100 27
  • 28. Effect of Prevalence : • Predictive values depend strongly on prevalence of the condition. • As the prevalence of the condition increases positive predictive value increases and thus more chances of getting true positive results. • If the condition is uncommon it is more sure that the negative test indicates no abnormality. 28
  • 29. • Higher the prevalence, higher is the predictive value. • Hence a screening program is most productive and efficient when it is directed to high risk target population. 29 Relationship B/W Predictive Value And Disease Prevalence
  • 30. Amount of previous unrecognized disease diagnosed as a result of screening effort. •Depends on Sensitivity, specificity. Prevalence of disease. Participation of individuals. • High risk populations selected for screening – 40 yrs. above adults for diabetes. 30 Yield
  • 31. Determining The Cutoff Point The factors to be considered are : • Disease prevalence : when prevalence of the disease is high in the community the cut-off point is set at low level. This will increase the sensitivity. • The disease : if the disease is very lethal and early intervention markedly increases the prognosis, cut off point is set at lower level. 31
  • 32. Receiver Operating Characteristic (ROC) Curve • The cutoff point for a disease is best determined using ROC curve. • As no single value cutoff point of an individual test can be expected to have both perfect sensitivity and specificity, it is often necessary to determine which value or cut off point is most appropriate for a given purpose. • Receiver Operating Characteristic (ROC) Curve is a graph displaying the relationship between true positive rate (on vertical axis) and false positive rate (on horizontal axis). • The ROC curve was first used during world war 2 for the analysis of RADAR signals for the detection of enemy objects entering the battle field. 32
  • 33. • A perfect test can be represented by drawing a line along the Y-axis and horizontal line on the top. • ROC curve of most of the tests appear as a curved line. Better the test, closer the curve approaches depiction of perfect test. 33
  • 34. 34 Uses Of ROC Curve: 1. ROC curve helps to choose the critical cut-off value which best discriminates the presence or absence of a disease. - At which the curve’s deviation is maximum. -Where the perpendicular distance from the line equality is maximum.
  • 35. 35 Test A Test B Uses Of ROC Curve: 2. Another use of ROC curve is to compare two indicators. The curve that contains a large area below it is a better predictor than one below with a smaller area.
  • 36. References • Park K. Park’s textbook of preventive and social medicine. 22nd ed. Jabalpur(India): Banarsidas Bhanot; 2012. p127-134. • Leon Gordis, Text book of epidemiology.4th ed.Saunders: Elsevier Inc.; 2009.p.85-108 • Sukon Kanchanaraksa.Evaluation of diagnostic and screening tests: validity and reliability, 1st edition. John hopkins bloomberg school of public health. 2011. p 1 – 124. 36
  • 37. 37

Notas del editor

  1. Screening is carried out in the hope that earlier diagnosis and subsequent rx favourably alters the natural history of the disease in a significant proportion of those who are identified as positive.